Phytochemicals Targeting Colorectal Cancer Growth and Metastasis

Santoshi Muppala1

  • 1Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA 44195.

Insights

Phytochemicals from natural sources show promise in inhibiting colorectal cancer (CRC) progression. This review highlights their potential as effective therapies targeting CRC growth and metastasis.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Identifying novel therapeutic strategies is crucial for improving patient outcomes.
  • Phytochemicals, natural compounds from plants, have demonstrated anti-cancer properties.

Purpose of the Study:

  • To review the role of phytochemicals in inhibiting colorectal cancer (CRC) progression.
  • To explore the mechanisms by which phytochemicals target cancer hallmarks.
  • To identify promising phytochemicals for CRC therapy development.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of research on phytochemicals and their derivatives.
  • Focus on compounds targeting CRC hallmarks like invasion, migration, proliferation, angiogenesis, immune evasion, and metastasis.

Main Results:

  • Phytochemicals exhibit potent inhibitory effects on CRC cell proliferation and metastasis.
  • These compounds target multiple hallmarks of cancer, including angiogenesis and immune surveillance evasion.
  • Evidence suggests phytochemicals can suppress CRC growth and metastasis effectively.

Conclusions:

  • Phytochemicals represent a promising class of natural compounds for CRC treatment.
  • Their ability to target diverse cancer mechanisms warrants further investigation for therapeutic development.
  • Phytochemicals offer a safe and effective avenue for developing novel CRC therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K